Creatine Monohydrate: 50 Years of Evidence

Creatine monohydrate was first identified as a component of skeletal muscle in the 1830s by French chemist Michel Eugène Chevreul. Its role in energy metabolism was elucidated over the following century. By the 1970s, researchers understood that creatine supplementation could increase intramuscular phosphocreatine stores. By the 1990s, it had become the most popular sports supplement in the world. By the 2020s, over 500 peer-reviewed studies had examined its effects on performance, body composition, and health.

The body of evidence is not modest. It is overwhelming. And the conclusions are remarkably consistent across decades, populations, and research groups.

The Mechanism

Creatine’s primary function in muscle tissue is serving as a substrate for the phosphocreatine energy system. During high-intensity exercise — sprints, heavy lifts, explosive movements — muscles use adenosine triphosphate (ATP) as the immediate energy currency. ATP stores are depleted within seconds. Phosphocreatine donates a phosphate group to regenerate ATP from adenosine diphosphate (ADP), extending the duration of maximal-effort work.

Supplemental creatine increases intramuscular phosphocreatine stores by 20 to 40%. This elevation translates directly to improved performance in activities that rely on the phosphocreatine system: repeated high-intensity efforts with short rest intervals, heavy resistance training, and sprint-based athletic tasks.

The mechanism is not hormonal. Creatine does not elevate testosterone, growth hormone, or insulin-like growth factor. It does not act as a stimulant. It simply increases the availability of the substrate used to regenerate ATP during anaerobic work. This mechanistic clarity is one reason the evidence base is so consistent — the pathway is well-defined and the outcome is directly measurable.

Performance Effects

A meta-analysis by Rawson and Volek (2003) pooled data from 22 studies examining creatine supplementation combined with resistance training. The findings:

• Creatine supplementation increased maximal strength by an average of 8% more than placebo.
• Weightlifting performance (total reps completed at a given intensity) improved by 14% more than placebo.
• Lean body mass gains were 0.36 kilograms greater per week of training with creatine compared to placebo.

These are not marginal effects. An 8% strength increase for an intermediate lifter squatting 150 kilograms represents an additional 12 kilograms on the bar — a meaningful jump that might otherwise take months to achieve through training alone.

The performance benefits are most pronounced in tasks involving repeated bouts of high-intensity effort: multiple sets of heavy squats, interval sprints, repeated jumps, and other activities where phosphocreatine resynthesis rate is the limiting factor. Endurance performance at low intensities shows minimal benefit, consistent with the mechanism — sustained aerobic work relies on oxidative phosphorylation rather than the phosphocreatine system.

Body Composition Effects

Creatine supplementation produces two distinct effects on body weight and composition.

Acute water retention: Within the first 5 to 7 days of loading, creatine draws water into muscle cells through osmotic effects. This produces a rapid weight gain of 1 to 3 kilograms, nearly all of which is intracellular water. This is sometimes cited as a negative — “it’s just water weight” — but intracellular hydration has its own physiological benefits. Cell swelling acts as an anabolic signal, activating pathways that promote protein synthesis and inhibit protein degradation.

Chronic lean mass gains: Over weeks and months of training with creatine supplementation, the performance enhancement — more reps, more total work, heavier loads — translates to greater mechanical stimulus and, consequently, greater muscle growth. Studies consistently show that creatine users gain 1 to 2 kilograms more lean body mass than non-users over 8 to 12 week training programs, independent of the initial water retention.

The net effect on body composition is favorable: more muscle, roughly equal fat gain (creatine does not promote lipogenesis), and improved strength that enables progressively heavier training loads over time.

Dosing Protocols

Two loading strategies are well-validated.

Loading protocol: 20 grams per day (divided into 4 doses of 5 grams) for 5 to 7 days, followed by a maintenance dose of 3 to 5 grams per day. This rapidly saturates intramuscular creatine stores and produces measurable performance benefits within the first week.

Chronic low-dose protocol: 3 to 5 grams per day from the start, without a loading phase. This achieves the same intramuscular saturation, but takes approximately 3 to 4 weeks to reach it. There is no long-term difference in efficacy between the two protocols — the loading phase simply accelerates the timeline.

For most lifters, the chronic low-dose approach is simpler and produces fewer gastrointestinal side effects (bloating and cramping during the loading phase are commonly reported). Five grams per day is the dose used in the majority of long-term studies.

Timing: The ISSN position stand notes that taking creatine close to training may offer a slight advantage over other timing, though the evidence is not definitive. The most practical approach is to take it with a meal containing carbohydrate and protein, which improves creatine uptake through insulin-mediated transport.

Cycling: There is no evidence that cycling creatine (taking periodic breaks from supplementation) provides any benefit. The body does not develop tolerance to creatine, and endogenous creatine production resumes normally when supplementation is discontinued. Continuous supplementation is the most straightforward approach.

Safety Profile

The safety data on creatine monohydrate is extensive and unambiguous.

Kidney function: The most persistent myth about creatine is that it damages the kidneys. This belief stems from the observation that creatine supplementation elevates serum creatinine — a metabolite used as a marker of kidney function. However, the elevation in creatinine is a direct consequence of increased creatine metabolism, not a sign of kidney damage. Every controlled study examining kidney function in healthy individuals using creatine at recommended doses has found no adverse effects on glomerular filtration rate or other markers of renal health.

The ISSN position stand states explicitly: “There is no scientific evidence that short- or long-term use of creatine monohydrate has any detrimental effects on otherwise healthy individuals.”

Liver function: No adverse effects have been documented at recommended doses.

Hydration and cramping: Early anecdotal reports linked creatine to dehydration and muscle cramping. Controlled research has not supported these claims. In fact, creatine supplementation increases total body water, and several studies have found lower rates of cramping and heat illness among creatine users compared to non-users.

Long-term use: Studies examining continuous creatine use over 1 to 5 years have identified no adverse health effects. The 2025 review by Forbes and colleagues concludes that creatine supplementation is safe and beneficial across the lifespan.

Beyond Performance: Emerging Health Applications

The research scope for creatine has expanded well beyond athletic performance.

Cognitive function: Creatine supplementation has shown modest benefits for cognitive performance, particularly under conditions of sleep deprivation or mental fatigue. The brain accounts for approximately 20% of the body’s energy expenditure, and cerebral creatine stores appear responsive to supplementation.

Traumatic brain injury: Preliminary evidence suggests creatine may reduce the severity of concussion symptoms and accelerate recovery from mild traumatic brain injury. The proposed mechanism involves maintenance of cellular energy status during the metabolic crisis that follows brain trauma.

Aging populations: Sarcopenia — age-related muscle loss — is a major contributor to frailty and mortality in older adults. Creatine supplementation combined with resistance training has shown greater improvements in lean mass and functional capacity in older adults compared to resistance training alone.

Bone health: Limited evidence suggests creatine may support bone mineral density through both direct effects on osteoblast activity and indirect effects via increased muscle mass and the mechanical loading it places on bone.

These applications are still in relatively early stages of investigation, but they reinforce the position that creatine monohydrate is not merely a sports supplement — it is a broadly beneficial nutritional compound with a favorable safety profile.

The “Which Form” Question

The supplement industry has produced numerous creatine variants: creatine ethyl ester, creatine hydrochloride, buffered creatine, creatine nitrate, and others. Each is marketed as superior to creatine monohydrate — better absorption, less bloating, more bioavailability.

The research does not support these claims. No alternative form of creatine has demonstrated superior efficacy to creatine monohydrate in any controlled trial. Creatine monohydrate remains the most studied, most effective, and least expensive form available.

The ISSN position stand recommends creatine monohydrate specifically as the only form with sufficient evidence to justify supplementation claims. Lifters spending premium prices on alternative forms are paying for marketing, not for superior biochemistry.

Fifty years of data, hundreds of studies, and millions of users have produced a rare thing in nutritional science: a clear and uncontested conclusion. Creatine monohydrate works. It is safe. And there is no reason to complicate it beyond five grams per day, taken consistently.

Lisa Beaumont is the Nutrition Editor at Fitpass Strength. She is a registered dietitian and ISSN-certified sports nutritionist with a focus on evidence-based performance nutrition.